Volitionrx Commences Lung Cancer Clinical Study With Fosun In China
Belgium Based Volitionrx Limited Has Executed A Contract Under The Previously Announced Memorandum Of Understanding, With Shanghai Fosun Long March Medical Science Co., Ltd. To Help Introduce The Nu.Q(Tm) Platform To China. Based On Recent Promising Proof-Of-Concept Data Using Volitions Product-Grade Nu.Q Assays, The Parties Have Commenced A Clinical Study In China In Lung Cancer.Dr. Jasmine Kway, Chief Executive Officer Of Singapore Volition, Commented: We Are Happy To Have Executed This Agreement With Fosun Long March And Are Delighted That The Clinical Study Is Already Underway And Expected To Be Completed By The End Of This Year."
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
